Client News

InfanDx receives BMBF grant to develop companion diagnostic test to identify newborns likely to benefit from neuroprotective hypothermia treatment

CENTOGENE AG: CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events

InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum

APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China

Imcyse SA: Imcyse to present late-breaking abstract of its Imotope™-based antigen-specific immunotherapy for autoimmune diseases at ASIT 2020

4basebio AG announces allotment ratio and final number of shares for the share buy back

Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock

Verona Pharma to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update

InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia